- Home
- VAL vs MLTX Comparison
VAL vs MLTX Comparison
Compare VAL & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VAL
- MLTX
- Stock Information
- Founded
- VAL 1975
- MLTX 2021
- Country
- VAL Bermuda
- MLTX Switzerland
- Employees
- VAL N/A
- MLTX N/A
- Industry
- VAL Oil & Gas Production
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- VAL Energy
- MLTX Health Care
- Exchange
- VAL Nasdaq
- MLTX Nasdaq
- Market Cap
- VAL 3.3B
- MLTX 2.8B
- IPO Year
- VAL N/A
- MLTX N/A
- Fundamental
- Price
- VAL $51.13
- MLTX $59.44
- Analyst Decision
- VAL Hold
- MLTX Strong Buy
- Analyst Count
- VAL 7
- MLTX 7
- Target Price
- VAL $46.33
- MLTX $74.83
- AVG Volume (30 Days)
- VAL 1.1M
- MLTX 446.5K
- Earning Date
- VAL 10-29-2025
- MLTX 08-05-2025
- Dividend Yield
- VAL N/A
- MLTX N/A
- EPS Growth
- VAL N/A
- MLTX N/A
- EPS
- VAL 3.83
- MLTX N/A
- Revenue
- VAL $2,463,400,000.00
- MLTX N/A
- Revenue This Year
- VAL N/A
- MLTX N/A
- Revenue Next Year
- VAL N/A
- MLTX N/A
- P/E Ratio
- VAL $13.40
- MLTX N/A
- Revenue Growth
- VAL 18.77
- MLTX N/A
- 52 Week Low
- VAL $27.15
- MLTX $31.42
- 52 Week High
- VAL $57.90
- MLTX $61.87
- Technical
- Relative Strength Index (RSI)
- VAL 63.44
- MLTX 68.36
- Support Level
- VAL $48.25
- MLTX $56.81
- Resistance Level
- VAL $50.12
- MLTX $61.87
- Average True Range (ATR)
- VAL 1.75
- MLTX 2.46
- MACD
- VAL 0.33
- MLTX 0.41
- Stochastic Oscillator
- VAL 95.00
- MLTX 75.33
About VAL Valaris Limited
Valaris Ltd is an offshore contract drilling company. The company provides offshore contract drilling services to the international oil and gas industry with operations in almost every offshore market across six continents. Its business consists of four operating segments: Floaters, which includes drillships and semisubmersible rigs; Jackups; ARO; and Other, which consists of management services on rigs owned by third parties. It generates the majority of its revenue from the Floaters segment.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.